Strategic Capital Advisers’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Strategic Capital Advisers's MRK Position: Q2 2022 in Review
Strategic Capital Advisers increased its Merck (MRK) stake by 10% in Q2 2022, buying an estimated $264K and bringing the position to 32,506 shares worth $2.96M. The position accounts for 2.45% of the portfolio, ranked #16.
Strategic Capital Advisers first reported a position in MRK in Q3 2020 and has held it in 8 quarters since. 3,015 funds tracked by Wall St. Rank hold MRK as of Q2 2022.
- Strategic Capital Advisers held 32,506 shares of Merck worth $2.96M as of Q2 2022.
- Strategic Capital Advisers bought 2,978 Merck shares in Q2 2022, an estimated $264K.
- Merck made up 2.45% of Strategic Capital Advisers's portfolio in Q2 2022, its #16 holding.
- Strategic Capital Advisers first reported a position in Merck in Q3 2020 and has held it in 8 quarters since.
- 3,015 funds tracked by Wall St. Rank held Merck as of Q2 2022.
Based on Strategic Capital Advisers's 13F filing for Q2 2022, filed 18 Jul 2022.